Chris Freeman

Chris Freeman serves as officer: Chief Commercial Officer at Guardant Health, Inc. (GH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$6.14M

Net Position

Net Seller

$6.14M

Companies Traded

Active Period

Dec 2025 – May 2026

2 total trades

Most Recent

Sell GH

May 26, 2026 · $2.90M

Chris Freeman's Insider Trading at Guardant Health, Inc. (GH)

Buys

0 · $0.00

Sells

2 · $6.14M

Total Shares Bought

Total Shares Sold

55,858

GH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 26, 2026	Sell	24,406	$118.67	$2.90M	60,034
Dec 8, 2025	Sell	31,452	$103.07	$3.24M	56,961

Related Insiders

Kumud Kalia

officer: Chief Information Officer

GHSell · Jun 12, 2026

Michael Brian Bell

officer: Chief Financial Officer

GHSell · Jun 8, 2026

Helmy Eltoukhy

director, officer: Co-Chief Executive Officer

GHSell · Jun 8, 2026

Steve E. Krognes

director

GHSell · Jun 5, 2026

Meghan V. Joyce

Director

GHSell · Jun 4, 2026

Medina Manuel Hidalgo

Director

GHSell · May 29, 2026

John G. Saia

officer: Chief Legal Officer

GHSell · May 28, 2026

CLARK IAN T

Director

GHSell · May 22, 2026

Explore More Insider Trading Data

GH Insider Trading Activity

View all insider trades at Guardant Health, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity